
Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer - PMC
LAG3 is the most promising immune checkpoint next to PD-1 and CTLA-4. High LAG3 and FGL1 expression boosts tumor growth by inhibiting the immune microenvironment. This review comprises four sections presenting the structure/expression, interaction, biological effects, and clinical application of LAG3/FGL1.
Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
2021年9月15日 · Fibrinogen-like protein 1 (FGL1) is a proliferation- and metabolism-related protein secreted by the liver. Multiple studies have confirmed that FGL1 is a newly emerging checkpoint ligand of lymphocyte activation gene 3 (LAG3), emphasizing the potential of targeting FGL1/LAG3 as the next generation of immune checkpoint therapy.
Florida Georgia Line Performs Together For The Last Time - TMZ
2022年9月1日 · Emotions were high at the Minnesota State Fair Wednesday night, as FGL did their last set ever ... before their final song, Tyler and brian took a minute to thank the crowd for being there for...
Fibrinogen like protein-1 knockdown suppresses the proliferation …
FGL-1 knockdown suppressed the proliferation of TU-686 cells by preventing them from entering S phase of the cell cycle. The FGL-1 knockdown cell line was constructed by lentiviral infection (Supplementary figure 1A). Western blot and qPCR were performed to confirm the knockdown efficiency (Supplementary figure 1B-C).
Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is ...
FGL1 was recently discovered to be the main ligand of immune checkpoint LAG-3 and play a critical role in the inhibition of T cells. However, the FGL1 expression in circulating tumor cells (CTCs) and its clinical significance in hepatocellular carcinoma (HCC) remain unclear.
The liver microenvironment orchestrates FGL1-mediated immune …
2023年10月23日 · Here, we identify that fibrinogen-like protein 1 (FGL1), secreted from cancer cells and hepatocytes, facilitates the progression of CRC in an intraportal injection model by reducing the...
FGL1:下一个免疫检查点靶点 - 药时代DrugTimes
2021年9月27日 · FGL1,也称为肝纤维蛋白原相关基因-1(LFIRE-1),是肝脏分泌的一种增殖和代谢相关因子。 它作为一种新的LAG3配体出现,能与LAG3结合形成独立于PD-1/PD-L1的新免疫检查点通路,导致T细胞耗竭和随后的功能障碍,以及肿瘤细胞逃避免疫监视。 除了在肝脏和胰腺中相对较高的表达外, FGL1在肿瘤组织(包括肺、前列腺、黑色素瘤、结直肠、乳腺和脑肿瘤)中表达上调。 因此,FGL1在临床实践中,特别是在非小细胞肺癌(NSCLC)的靶向治疗 …
Impact of the Neural Cell Adhesion Molecule-Derived Peptide FGL …
2014年3月3日 · The impact of FGL on kindling progression is indicated by a reduced number of stimulations necessary to induce a generalized seizure. These data might suggest that FGL can promote the development of an epileptogenic network with …
The FGL-1/LAG-3 Axis is Associated With Disease Course in …
2025年1月1日 · The acute phase protein fibrinogen-like protein 1 (FGL-1) produced by hepatocytes stimulates hepatocyte proliferation by autocrine signaling. FGL-1 also is a ligand for the inhibitory T cell receptor lymphocyte activation gene 3 (LAG-3). In these ways, FGL-1 and LAG-3 have beneficial interactions that could be interrupted in AH.
FGL2: A new target molecule for coagulation and immune …
2024年12月25日 · FGL2, with its two forms sFGL2 and mFGL2, demonstrates diverse immunomodulatory and prothrombin functions across infection stages. In malaria, FGL2 exacerbates the disease by suppressing the immune response during the blood stage of the infection, but not the liver stage.